Leroue, Matthew K.
Williamson, Kayla M.
Curtin, Paul C.
Sontag, Marci K.
Wagner, Brandie D.
Ambroggio, Lilliam
Bixby, Moira
Busgang, Stefanie A.
Murphy, Sharon E.
Peterson, Lisa A.
Vevang, Karin R.
Sipe, Christopher J.
Kirk Harris, J.
Reeder, Ron W.
Locandro, Christopher
Carpenter, Todd C.
Maddux, Aline B.
Simões, Eric A. F.
Osborne, Christina M.
Robertson, Charles E.
Langelier, Charles
Carcillo, Joseph A.
Meert, Kathleen L.
Pollack, Murray M.
McQuillen, Patrick S.
Mourani, Peter M.
Article History
Received: 8 June 2022
Revised: 18 December 2022
Accepted: 16 January 2023
First Online: 7 February 2023
Competing interests
: M.K.L. has nothing to disclose. K.M.W. has nothing to disclose. P.C.C. reports grants from NIH during the conduct of the study. M.K.S. reports grants from NIH NHLDI during the conduct of the study. L.A. reports grant funding from Pfizier Inc. outside the submitted work. M.B. has nothing to disclose. S.A.B. has nothing to disclose. S.E.M. has nothing to disclose. L.A.P. has nothing to disclose. J.K.H. has nothing to disclose. R.W.R. has nothing to disclose. C.L. has nothing to disclose. T.C.C. reports grants from NIH NHLBI during the conduct of the study. A.B.M. reports a grant from Parker B. Francis Foundation and NIH NICHD, outside the submitted work. E.A.F.S. reports grants from Astra Zeneca Inc, Merck & Co, Regeneron Inc, Pfizer Inc, Roche Inc, Johnson and Johnson, and Novavax Inc; consulting fees from Merck & Co, Pfizer Inc, Alere Inc, Cidara Therapeutics, and Sanofi Pasteur; support from travel from Merck & Co and Pfizer Inc; participation on Data Safety and Monitoring Boards with Abbvie, Glasco Smith Klein and the Bill and Melinda Gates Foundation all outside of the submitted work. C.M.O. has nothing to disclose. C.E.R. has nothing to disclose. C.L. has nothing to disclose. J.A.C. has nothing to disclose. K.L.M. has nothing to disclose. M.M.P. reports grants from the NIH during the conduct of the study. P.S.M. has nothing to disclose. P.M.M. reports grants from NIH NIHLBI and NIH NICHD during the conduct of the study.
: The study was approved by the University of Utah central Institutional Review Board and consent was obtained from all patients.
Free to read: This content has been made available to all.